Bernicke Wealth Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-12,675
Closed -$684K 48
2019
Q1
$684K Buy
12,675
+702
+6% +$43.3K 0.43% 41
2018
Q4
$784K Buy
11,973
+639
+6% +$47.7K 0.54% 30
2018
Q3
$892K Buy
11,334
+970
+9% +$69.3K 0.59% 20
2018
Q2
$667K Buy
10,364
+2,125
+26% +$140K 0.47% 36
2018
Q1
$513K Buy
8,239
+1,238
+18% +$88.8K 0.37% 45
2017
Q4
$508K Buy
7,001
+687
+11% +$49.9K 0.38% 44
2017
Q3
$513K Buy
6,314
+965
+18% +$76.3K 0.4% 34
2017
Q2
$430K Buy
5,349
+2,032
+61% +$160K 0.34% 37
2017
Q1
$260K Buy
+3,317
New +$265K 0.22% 55

Other funds holding CVS

Bernicke Wealth Management's CVS Position: Q2 2019 in Review

Bernicke Wealth Management sold out of CVS Health (CVS) in Q2 2019, closing a stake of 12,675 shares — an estimated $684K sold.

Bernicke Wealth Management first reported a position in CVS in Q1 2017 and held it in 9 quarters. The position peaked at $892K in Q3 2018. 1,654 funds tracked by Wall St. Rank hold CVS as of Q2 2019.

  • Bernicke Wealth Management reported no remaining CVS Health position as of Q2 2019 after selling out during the quarter.
  • Bernicke Wealth Management sold 12,675 CVS Health shares in Q2 2019, an estimated $684K.
  • Bernicke Wealth Management first reported a position in CVS Health in Q1 2017 and held it in 9 quarters.
  • Bernicke Wealth Management's CVS Health position peaked at $892K in Q3 2018.
  • 1,654 funds tracked by Wall St. Rank held CVS Health as of Q2 2019.

Based on Bernicke Wealth Management's 13F filing for Q2 2019, filed 5 Aug 2019.